Jeroen de Baaij, theme Renal disorders, was awarded with an Innovation Grant of the Dutch Kidney Foundation (Nierstichting). Jeroen's research proposal 'The HNF1B switch: Single-cell RNA sequencing to unravel renal cyst formation in ADTKD-HNF1B' was selected from a competitive field of innovative approaches to treat kidney disease.Jeroen de Baaij
The project aims to understand renal cyst formation in patients with autosomal dominant tubulointerstitial kidney disease. This rare disease is caused by mutations in the HNF1B gene. Patients suffer from renal cysts, hypomagnesemia and diabetes. In the kidneys of these patients some cells form renal cysts, whereas other cells don’t. This project aims to decipher which mechanisms drive cells into cyst formation. By applying the innovative single-cell RNA-seq technique on renal cells, it will be possible to identify the mechanisms of renal cyst formation.
The Dutch Kidney Foundation aims to stimulate the quality of the renal scientific field in the Netherlands through providing grants that support innovation in the Netherlands. The program establishes stronger links between innovative research and patient care. By providing better understanding of cyst formation, the ultimate goal of improving treatment of patients with tubulointerstitial kidney disease may come one step closer.
Related news items
Jong KNCV organizes a Pitch competition for PhD candidates13 August 2020
Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.read more
Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels13 August 2020
Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.read more
TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer12 August 2020
An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.read more
BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea11 August 2020
The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.read more
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more